|
Report Date : |
13.08.2012 |
IDENTIFICATION DETAILS
|
Name : |
CI FARMACAPSULAS SA |
|
|
|
|
Registered Office : |
Calle 79B Nro. 78C-21, Barranquilla, Atlantico 080100 |
|
|
|
|
Country : |
Columbia |
|
|
|
|
Year of Establishment : |
1985 |
|
|
|
|
Legal Form : |
Sociedad Anonima |
|
|
|
|
Line of Business : |
Manufacturer of pharmaceutical capsules |
|
|
|
|
No. of Employees : |
600 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Columbia |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
POLITICAL DATA |
ECONOMIC DATA |
|
Form of Government: Republic
|
Currency: 1.00 COP = 0.000557880 USD |
|
Legal Name: |
CI FARMACAPSULAS SA |
||
|
|
|
||
|
Legal Address |
Calle 79B Nro. 78C-21, Barranquilla, Atlantico 080100, Colombia |
||
|
Operative Address |
Calle 79B Nro. 78C-21, Barranquilla, Atlantico 080100, Colombia |
||
|
Telephone: |
+57 (5) 330-4100 |
NIT : |
890105927 |
|
Fax: |
+57 (5) 330-4197 |
Legal Form: |
Sociedad Anonima |
|
Email: |
Registered in: |
Colombia |
|
|
Website: |
Date Created: |
1985 |
|
|
Manager: |
Saul Gilinski, Chairman |
Date Incorporated: |
May 13th 1975 |
|
Staff: |
600 |
Stock: |
NA |
|
|
|
Value: |
NA |
|
Activity: |
Manufacturer of pharmaceutical capsules. |
||
|
Name of the Bank |
Bancolombia |
|
HISTORY |
|
|
|
The company was created in 1985. |
|
PRINCIPAL ACTIVITY |
|
|
|
C.I. Farmacapsulas S.A. manufactures gelatin and vegetable-derived
two-piece capsules for pharmaceutical and health nutrition companies in Colombia
and internationally. |
|
Products/Services description: |
|
|
|
The company also offers contract manufacturing services for
pharmaceutical oral dosage forms, including modified release pellets, liquid-filled
capsules, tablets, suspensions, non effervescent powder, liquids, and two
pieces capsules. It develops and manufactures oral pharmaceuticals. |
|
Sales are: |
|
|
|
Wholesale |
|
Clients: |
|
|
|
Pharmaceutical and health nutrition companies. |
|
Operations area: |
|
|
|
National, International, Local |
|
The company imports from depending on demand |
|
|
The company exports to Perú, Bolivia, Chile, Argentina, Paraguay,
Brazil, Venezuela, Central America and USA |
|
|
Trade References: |
|
|
|
The person contacted refused to provide the names of their suppliers
for us to check the trade references. |
|
The subject employs 600 employee(s) |
|
|
Comments on staff: |
|
|
|
This information could not be confirmed by the staff. |
|
PAYMENTS |
|
|
|
regular |
|
LOCATION |
|
|
Headquarters |
|
|
|
The company is headquartered at Calle 79B Nro. 78C-21, Barranquilla,
Atlantico 080100, Colombia. |
- Manager - Related
Companies
|
Listed at the stock exchange: |
|
|
|
NO |
|
Shareholders Parent Company(ies): |
|
|
|
This is a private company. Despite our long searches we could not
confirm the current shareholders. |
|
Management: |
|
|
|
Saul Gilinski, Chairman, Legal representative Florette Mendal De Gilinski, Deputy Legal representative (1st) Gloria Eugenia Henao Jinete, Deputy Legal representative (2nd) Luis Alberto Ledesma Angulo, Accountant |
- COMMERCIAL TRENDS AND FORECAST
|
As a private company the subject does not publish any financial
statements. |
|
We have contacted the company but we were unable to speak with a
representative. |
|
However our financial sources could provide us with the following
data. Those figures are estimates provided by confidential banking and
financial institutions working with the company. |
|
Currency |
DATE |
|
COP |
2011 |
|
Turnover |
93,147,133,000 |
|
Operating Income |
4,033,821,000 |
|
Net Income |
3,530,992,000 |
|
Current Assets |
113,936,809,000 |
|
Fixed Assets |
63,463,334,000 |
|
Net worth |
82,468,843,000 |
|
Liabilities |
94,931,300,000 |
|
Bank liabilities |
33,678,889,000 |
|
The cash flow is |
NORMAL |
|
Legal Fillings |
|
The sources consulted record no
detrimental legal or labor court information. |
|
Local credit bureau gave a correct credit rate. The company is in Good Standing. This means that all local and federal
taxes were paid on due date. |
|
|
Final Opinion
|
|
|
|
The subject is a big size Colombian company. It started its operations in 1985. Therefore, it has a very good
experience in its field. CI FARMACAPSULAS SA manufactures pharmaceutical capsules. The company has operations national and internationally, as well. It seems to have an adequate business structure, based on the
information found regarding its size and commercial operations. No specific adverse record has been found on the subject. |
|
|
|
||
|
Profitability |
CORRECT |
Public |
NO |
|
Indebtedness |
LOW |
Payments |
REGULAR |
|
Cash |
NORMAL |
|
|
|
Comments |
|
|
|
We have tried to contact the company but we were directed to a
voicemail that stated the company has recently changed its
"extensions". We dialed different numbers in order to reach a
representative but we were directed to the same voicemail. We could not leave
a message. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.34 |
|
UK Pound |
1 |
Rs.86.45 |
|
Euro |
1 |
Rs.68.43 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.